Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011173544> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2011173544 endingPage "623" @default.
- W2011173544 startingPage "616" @default.
- W2011173544 abstract "The antitumor activity of a newly obtained cyclic hexapeptide, RA-700, from Rubiae Radix was studied using several murine experimental tumor systems. In P388 leukemia (inoculated intraperitoneally (i.p.), administered i.p.: i.p.-i.p.) the maximal increase in life span (ILSmax) resulting from an administration of RA-700 (4 mg/kg/d for 9 d) was 134% and the therapeutic ratio was 400. These values indicate that RA-700 has higher anti-tumor activity and broader active dose range than that of mitomycin C (MMC, 1 mg/kg/d for 9 d) which was used as a positive control. In the study of the treatment schedules on P388, RA-700 had the highest activity by consecutive injections. In MOPC-104E mouse plasmacytoma system (i.p.-i.p.), ILSmax of RA-700 (2.5 mg/kg/d for 9 d) was 84%. In a solid tumor, colon adenocarcinoma 38 (subcutaneously (s.c.)-intravenously (i.v.], RA-700 (4 mg/kg/d for 11 d) showed complete cures (8/8) compared to MMC (0.5 mg/kg/d for 11 d) which showed one cure out of 8 animals. In the study of a model of the inhibition of lymph node metastasis using P388 leukemia, the administration of RA-700 at more than 2.5 mg/kg/d i.v. for 7 d resulted in the survival of all animals (5/5) for over 60 d. In the amputation system of the same metastasis model at a dose of 4 mg/kg/d i.v. for 7 d, 3 animals out of 5 survived over 60 d.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W2011173544 created "2016-06-24" @default.
- W2011173544 creator A5028807109 @default.
- W2011173544 creator A5033231895 @default.
- W2011173544 creator A5033562835 @default.
- W2011173544 creator A5042480948 @default.
- W2011173544 creator A5060093615 @default.
- W2011173544 creator A5080663449 @default.
- W2011173544 date "1987-01-01" @default.
- W2011173544 modified "2023-09-26" @default.
- W2011173544 title "A novel antitumor cyclic hexapeptide (RA-700) obtained from Rubiae Radix." @default.
- W2011173544 cites W1484429430 @default.
- W2011173544 cites W1514421181 @default.
- W2011173544 cites W1980427312 @default.
- W2011173544 cites W1991727686 @default.
- W2011173544 cites W2008433517 @default.
- W2011173544 cites W2018791924 @default.
- W2011173544 cites W2025478017 @default.
- W2011173544 cites W2076084146 @default.
- W2011173544 cites W2164629825 @default.
- W2011173544 cites W2237040806 @default.
- W2011173544 cites W2322576711 @default.
- W2011173544 cites W2325847105 @default.
- W2011173544 cites W2331488425 @default.
- W2011173544 cites W2397336788 @default.
- W2011173544 cites W2416899887 @default.
- W2011173544 cites W2467718191 @default.
- W2011173544 doi "https://doi.org/10.1248/bpb1978.10.616" @default.
- W2011173544 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3128656" @default.
- W2011173544 hasPublicationYear "1987" @default.
- W2011173544 type Work @default.
- W2011173544 sameAs 2011173544 @default.
- W2011173544 citedByCount "7" @default.
- W2011173544 countsByYear W20111735442017 @default.
- W2011173544 crossrefType "journal-article" @default.
- W2011173544 hasAuthorship W2011173544A5028807109 @default.
- W2011173544 hasAuthorship W2011173544A5033231895 @default.
- W2011173544 hasAuthorship W2011173544A5033562835 @default.
- W2011173544 hasAuthorship W2011173544A5042480948 @default.
- W2011173544 hasAuthorship W2011173544A5060093615 @default.
- W2011173544 hasAuthorship W2011173544A5080663449 @default.
- W2011173544 hasBestOaLocation W20111735441 @default.
- W2011173544 hasConcept C121608353 @default.
- W2011173544 hasConcept C126322002 @default.
- W2011173544 hasConcept C141071460 @default.
- W2011173544 hasConcept C2776694085 @default.
- W2011173544 hasConcept C2779013556 @default.
- W2011173544 hasConcept C2779338040 @default.
- W2011173544 hasConcept C71924100 @default.
- W2011173544 hasConcept C98274493 @default.
- W2011173544 hasConceptScore W2011173544C121608353 @default.
- W2011173544 hasConceptScore W2011173544C126322002 @default.
- W2011173544 hasConceptScore W2011173544C141071460 @default.
- W2011173544 hasConceptScore W2011173544C2776694085 @default.
- W2011173544 hasConceptScore W2011173544C2779013556 @default.
- W2011173544 hasConceptScore W2011173544C2779338040 @default.
- W2011173544 hasConceptScore W2011173544C71924100 @default.
- W2011173544 hasConceptScore W2011173544C98274493 @default.
- W2011173544 hasIssue "11" @default.
- W2011173544 hasLocation W20111735441 @default.
- W2011173544 hasLocation W20111735442 @default.
- W2011173544 hasOpenAccess W2011173544 @default.
- W2011173544 hasPrimaryLocation W20111735441 @default.
- W2011173544 hasRelatedWork W1484554393 @default.
- W2011173544 hasRelatedWork W1998997581 @default.
- W2011173544 hasRelatedWork W1999037563 @default.
- W2011173544 hasRelatedWork W2041039905 @default.
- W2011173544 hasRelatedWork W2130659749 @default.
- W2011173544 hasRelatedWork W2357999979 @default.
- W2011173544 hasRelatedWork W2371666691 @default.
- W2011173544 hasRelatedWork W2378355431 @default.
- W2011173544 hasRelatedWork W2417188508 @default.
- W2011173544 hasRelatedWork W3111930657 @default.
- W2011173544 hasVolume "10" @default.
- W2011173544 isParatext "false" @default.
- W2011173544 isRetracted "false" @default.
- W2011173544 magId "2011173544" @default.
- W2011173544 workType "article" @default.